Fidelity International’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-112,956
| Closed | -$1.21M | – | 904 |
|
|
2019
Q1 | $1.21M | Sell |
112,956
-454,036
| -80% | -$4.88M | ﹤0.01% | 593 |
|
|
2018
Q4 | $8.56M | Buy |
566,992
+5,282
| +0.9% | +$79.8K | 0.02% | 452 |
|
|
2018
Q3 | $10.4M | Buy |
561,710
+1,695
| +0.3% | +$31.4K | 0.02% | 482 |
|
|
2018
Q2 | $12.8M | Buy |
560,015
+130,090
| +30% | +$2.97M | 0.02% | 464 |
|
|
2018
Q1 | $12.2M | Buy |
429,925
+114,962
| +37% | +$3.27M | 0.03% | 332 |
|
|
2017
Q4 | $6.65M | Buy |
314,963
+200,058
| +174% | +$4.22M | 0.02% | 386 |
|
|
2017
Q3 | $2.09M | Buy |
+114,905
| New | +$2.09M | 0.01% | 447 |
|